World Vaccine Congress Washington DC 2023
Join our team as we exhibit and present at World Vaccine Congress USA in Washington DC. We invite you to visit us at booth #901 to say hello.
What, where, and when?
- What: World Vaccine Congress Washington DC
- Where: Walter E. Washington Convention Center, booth #901
- When: 3 - 6 April 2023
This is a LIVE IN-PERSON EVENT.
Book a meeting with our experts here
![Avanti Polar Lipids and Croda Pharma logos](/mediaassets/images/health-care/health-care-new-website/landing-pages/avanti--croda-website-logos.png?w=1920&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=BA6C23D2202189B26E1B3884518F97C3)
Addressing the challenges of vaccine formulation
![2022 Adjuvants Brochure](/mediaassets/images/health-care/health-care-new-website/png/cover-image--new-adjuvants-brochure.png?w=500&la=en-GB&focalpointcrop=1&xratio=105&yratio=140&hash=ECDC269CC09D15EB3FA3DD89135FB1A9)
Discover more about our strategic partnerships with industry leaders
On Wednesday 5 April at 16:40, Dr. Dennis Christensen will host a presentation titled Ensuring clinical availability of vaccine delivery systems, immunostimulators & combined adjuvant systems. See the full agenda here
![](/mediaassets/images/health-care/health-care-new-website/authors-and-headshots/dennis-christensen-small.png?la=en-gb&hash=97D594E88530C037C8FC92A6B5DE2158)
Learn with Dr. Dennis Christensen
• The importance of having vaccine delivery systems, immunostimulators and combined adjuvants without risk of supply
• The industry manufacturing challenges while under demand stress due to a global pandemic
• The need for commercial availability of novel vaccine delivery systems, immunostimulators and combined adjuvant systems.
Request a meeting here
How can we hep you with your vaccine research and projects?
Visit our scientists and industry experts at the booth, to discuss our solutions, including Adjuvant Systems, innovative GMP lipids and high purity excipients from Croda Pharma and Avanti Polar Lipids.
About our poster session:
Using high purity compendial excipients would be beneficial due to the prone oxidation in excipients commonly used in ophthalmic formulation. In our study, we aim to reduce oxidative impurities in ophthalmic excipients and compare different purity materials for stability over long term. Visit our poster session to discover our findings and see the benefits of Super Refined™ excipients.
-
Title: Increasing oxidative stability with high purity excipients used in ophthalmic formulations
-
Poster number: T1330-01-03
-
Poster presentation: October 24, 1:30pm, forum number 01, monitor number 03
Event type: Conference
World Vaccine Congress Washington, DC
The World Vaccine Congress Washington, DC meeting is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain. Take this opportunity to meet our scientists and experts to learn how we are expanding our offering and unlock sustainable ingredients for vaccines. We will be showcasing our vaccine adjuvants and immunostimulators portfolio which includes components for well-studied and novel adjuvants systems. Discover our ability to offer sustainably sourced squalene and QS-21 in the future. Schedule a meeting with us or meet us at booth #419!